Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Helsinn Healthcare S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Helsinn Healthcare S.A. - Product Pipeline Review - 2014', provides an overview of the Helsinn Healthcare S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Helsinn Healthcare S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Helsinn Healthcare S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Helsinn Healthcare S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Helsinn Healthcare S.A.'s pipeline products Reasons to buy - Evaluate Helsinn Healthcare S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Helsinn Healthcare S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Helsinn Healthcare S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Helsinn Healthcare S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Helsinn Healthcare S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Helsinn Healthcare S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Helsinn Healthcare S.A. Snapshot 5 Helsinn Healthcare S.A. Overview 5 Key Information 5 Key Facts 5 Helsinn Healthcare S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Helsinn Healthcare S.A. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Helsinn Healthcare S.A. - Pipeline Products Glance 12 Helsinn Healthcare S.A. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Phase III Products/Combination Treatment Modalities 13 Helsinn Healthcare S.A. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Helsinn Healthcare S.A. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Helsinn Healthcare S.A. - Drug Profiles 17 (netupitant + palonosetron) 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 anamorelin hydrochloride 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 ATH-008 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 elsiglutide 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 ipamorelin 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Drug to Agonize Ghrelin Receptor for Cancer Cachexia and Anorexia 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecule to Agonize Ghrelin Receptor for Gastric Disorder 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecules to Antagonize Ghrelin Receptor for Obesity 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Small Molecule to Inverse Agonize Ghrelin Receptor for Obesity 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Helsinn Healthcare S.A. - Pipeline Analysis 28 Helsinn Healthcare S.A. - Pipeline Products by Target 28 Helsinn Healthcare S.A. - Pipeline Products by Route of Administration 29 Helsinn Healthcare S.A. - Pipeline Products by Molecule Type 30 Helsinn Healthcare S.A. - Pipeline Products by Mechanism of Action 31 Helsinn Healthcare S.A. - Recent Pipeline Updates 32 Helsinn Healthcare S.A. - Dormant Projects 37 Helsinn Healthcare S.A. - Discontinued Pipeline Products 38 Discontinued Pipeline Product Profiles 38 becatecarin 38 Helsinn Healthcare S.A. - Locations And Subsidiaries 39 Head Office 39 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 41 Disclaimer 41
List of Tables Helsinn Healthcare S.A., Key Information 5 Helsinn Healthcare S.A., Key Facts 5 Helsinn Healthcare S.A. - Pipeline by Indication, 2014 8 Helsinn Healthcare S.A. - Pipeline by Stage of Development, 2014 9 Helsinn Healthcare S.A. - Monotherapy Products in Pipeline, 2014 10 Helsinn Healthcare S.A. - Combination Treatment Modalities in Pipeline, 2014 11 Helsinn Healthcare S.A. - Pre-Registration, 2014 12 Helsinn Healthcare S.A. - Phase III, 2014 13 Helsinn Healthcare S.A. - Phase II, 2014 14 Helsinn Healthcare S.A. - Preclinical, 2014 15 Helsinn Healthcare S.A. - Discovery, 2014 16 Helsinn Healthcare S.A. - Pipeline by Target, 2014 28 Helsinn Healthcare S.A. - Pipeline by Route of Administration, 2014 29 Helsinn Healthcare S.A. - Pipeline by Molecule Type, 2014 30 Helsinn Healthcare S.A. - Pipeline Products by Mechanism of Action, 2014 31 Helsinn Healthcare S.A. - Recent Pipeline Updates, 2014 32 Helsinn Healthcare S.A. - Dormant Developmental Projects,2014 37 Helsinn Healthcare S.A. - Discontinued Pipeline Products, 2014 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.